Antiplatelet Therapy in Stable Coronary Artery Disease
Stable coronary artery disease (CAD) affects around 200 million people worldwide. Recent evidence with P2Y12 inhibitors, direct oral anticoagulants, and combination strategies has challenged aspirin monotherapy as the standard antithrombotic approach.
Authors
- Ahmed K. Alsaif
- Atheer Fawaz Alhamyani
- Terad Talmesany
- Danah Abdulaziz Alghamdi
- Shaima Dhaher Aljohani
- Atheer Atiah Alghamdi
- Miad Abdullah Alzahrani
- Ahmed Y. Azzam
- Rawan Mohammed Alzahrani
- Lama Saleh Alghamdi
Institutions
- Taif University (SA)
- Taibah University (SA)
- Al-Ghad International Health Sciences Colleges (SA)
- Artificial Intelligence in Medicine (Canada) (CA)
- Al Baha University (SA)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.jacadv.2026.102633
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00